97 results on '"Sternieri E"'
Search Results
2. High Efficacy and Low Frequency of Headache Recurrence after Oral Sumatriptan
3. Rizatriptan efficacy is not related to the occurence of cutaneous allodyniain migrain without aura
4. Cefalea attribuita all'uso di sostanze o alla loro sospensione
5. Efficacia di rizatriptan in relazione alla presenza di allodinia cutanea in pazienti affetti da emicrania senz’aura. Risultati preliminari
6. Lessons from triptans in migraine treatment
7. Triptans: what is the clinical importance of kinetic differences?
8. Management of patients with primary headache by headache centres improves quality of life
9. Variability of oral sumatriptan pharmacokinetics in migraine patients
10. Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal of the overused combination of indomethacin, prochlorperazine, and caffeine
11. The GHB-analogue, GET 73, prevents either the development of preference for sucrose in non-stressed rats, or the reduction of sucrose intake in chronically stressed rats
12. Proposal of changing subtype 8.1 'Headache induced by acute substance use or exposure' and subtype 8.3 'Headache as an adverse event attributed to chronic medication' of ICHD-II
13. Limits of medication-overuse headache classification (code 8.2 according to ICHD-II)'
14. Pharmacoepidemiology of drug abuse in headache patients: comparison between sufferers of medication-overuse headache and migraine
15. Experience with the drug information service of the university hospital of Modena
16. Analysis of three-year activity of an information service on doping
17. Assessment of the efficacy and tolerability of triptans in clinical practice
18. Treatment of chronic migraine and medication overuse
19. Medication-Overuse Headache: clinical and therapeutic problems
20. Pharmacoepidemiology of headache treatment before and after referral to a specialist centre
21. Telefono pulito', (Clean Telephone'), an Italian Telephone advice and information Service on Doping Agents and frequently used substances in sport practice. Activity Report
22. Kinetics of indomethacin in headache patients who abitually take an association of indomethacin, caffeine and prochlorperazine
23. Prevalenza di eventi avversi correlati all’assunzione di farmaci comunemente impiegati per il trattamento acuto e di profilassi delle cefalee
24. Adverse event from drugs commonly employed in the headache attack treatment and prophylaxis: reuslts from a pharmacovigilance survey
25. How are managed headache sufferers outside from specialized centres? A pharmaco-epidemiology report
26. I farmaci di profilassi: strategie d’impiego
27. Drug craving evaluation in chronic headache patients, episodic headache patients and addicts trough the Leeds dependence questionnaire (LDQ)'
28. La gestione del paziente cefalalgico in 21 Centri Cefalee Italiani
29. Serotoninergic system changes during heroin abuse and their reversibility after abuse discontinuation
30. Il problema dell’abuso
31. DRGs e Centri Cefalee
32. Cefalea come effetto indesiderato dei farmaci
33. Profilo di tollerabilità dei triptani
34. Serum concentrations of vitamin B12 and folate in chronic daily headache
35. L’uso quotidiano di analgesici è causa od effetto della cronicizzazione di una cefalea?
36. Cefalee da farmaci
37. L’evoluzione clinica dell’emicrania può essere modificata dalla modulazione della terapia
38. La Cefalea da abuso di analgesici' analizzata alla luce della 'evidence based medicine'
39. Recommendations for the reliable detection of illicit drugs in urine, with special attention to the workplace, in the European Union (December 1996)
40. Farmacologia e Tossicologia
41. Trattamento farmacologico del dolore postoperatorio
42. Le neuropatie da farmaci
43. Il ruolo del fattori farmacologici nella trasformazione della cefalea episodiche in croniche quotidiane
44. Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania
45. Treatment with naltrexone
46. Detoxification from opioids with clonidine, clonidine-naloxone and clonidine-naltrexone
47. Chronic headache and analgesic abuse
48. Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente
49. Accanimento terapeutico o riduzione del danno
50. Prevalenza e frequenza dell’uso di cocaina in un campione di tossicodipendenti del territorio modenese
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.